Search

Your search keyword '"Aida Botelho de Sousa"' showing total 3 results
Start Over Author "Aida Botelho de Sousa" Journal leukemia & lymphoma
3 results on '"Aida Botelho de Sousa"'

1. Second autologous stem cell transplantation for relapsed/refractory Hodgkin lymphoma after a previous autograft: a study of the lymphoma working party of the EBMT

Author

Edgar Faber, Aida Botelho de Sousa, Ibrahim Yakoub-Agha, Irma Khvedelidze, Xavier Poiré, Ariane Boumendil, Joanna Romejko-Jarosinska, Anna Sureda, Herve Finel, Hervé Ghesquières, Kazimierz Hałaburda, Achilles Anagnostopoulos, Saad Akhtar, Carmen Martínez, Silvia Montoto, Vincenzo Pavone, and Gunhan Gurman

Subjects
Oncology, Cancer Research, medicine.medical_specialty, Lymphoma, medicine.medical_treatment, Hematopoietic stem cell transplantation, Transplantation, Autologous, Disease-Free Survival, 03 medical and health sciences, 0302 clinical medicine, Autologous stem-cell transplantation, Refractory, Recurrence, immune system diseases, hemic and lymphatic diseases, Internal medicine, Refractory Hodgkin Lymphoma, medicine, Humans, Autografts, business.industry, Hematopoietic Stem Cell Transplantation, Hematology, medicine.disease, Hodgkin Disease, 030220 oncology & carcinogenesis, Relapsed refractory, Hodgkin lymphoma, Neoplasm Recurrence, Local, business, Stem Cell Transplantation, 030215 immunology
Abstract

The purpose of this study was to analyze the results of second autologous hematopoietic stem cell transplantation (ASCT2) for patients with relapsed/refractory Hodgkin lymphoma (HL) after a first transplantation (ASCT1). Outcomes for 56 patients receiving an ASCT2 registered in the EBMT database were analyzed. The 4-year cumulative incidences of non-relapse mortality and disease relapse/progression were 5% and 67%, respectively. The 4-year overall survival (OS) and progression-free survival (PFS) were 62% and 28%. In univariate analysis, relapse of HL within 12 months of ASCT1 was associated with a worse OS (35% versus 76%

Published
2020

2. A novel mutation in CEBPA gene in a patient with acute myeloid leukemia

Author

Alexandra Lourenço, Patrícia Ribeiro, Alexandra R. Fernandes, Raquel Vinhas, Aida Botelho de Sousa, Rafaela Canto, Pedro V. Baptista, and Anna Tolmatcheva

Subjects
0301 basic medicine, Cancer Research, Mutation, Acute leukemia, Myeloid, business.industry, Myeloid leukemia, Hematology, medicine.disease_cause, medicine.disease, Bioinformatics, Hematopoietic malignancy, 03 medical and health sciences, Leukemia, 030104 developmental biology, medicine.anatomical_structure, Oncology, hemic and lymphatic diseases, CEBPA, medicine, Cancer research, business, Novel mutation
Abstract

Acute myeloid leukemia (AML) is a hematopoietic malignancy characterized by clonal expansion of myeloid progenitor cells accounting for the majority of acute leukemia cases in adults, despite the h...

Published
2015

3. An e6a2 BCR-ABL fusion transcript in a CML patient having an iliac chloroma at initial presentation

Author

Purificação Tavares, António Sebastião Rodrigues, Aida Botelho de Sousa, Mónica Pereira, Anna Ivanova-Dragoeva, Fátima Torres, Joana Veiga, and Alexandra R. Fernandes

Subjects
congenital, hereditary, and neonatal diseases and abnormalities, Cancer Research, business.industry, Myeloid leukemia, Chromosomal translocation, Hematology, Philadelphia chromosome, medicine.disease, Oncology, Fusion transcript, hemic and lymphatic diseases, Cancer research, Medicine, Presentation (obstetrics), business
Abstract

Philadelphia chromosome (Ph1), which results from the reciprocal translocation t(9;22)(q34;q11), is the hallmark of almost all the cases of chronic myeloid leukemia (CML). Most patients express eit...

Published
2007

Catalog

Books, media, physical & digital resources
See catalog results